We examined the relationship between COMT Val158Met genotype and temporal lobe volumes, including the caudate as a control region. Thirty-one healthy subjects completed 1.5T brain MRI and genotyping. After controlling for demographics, Val158 allele homozygotes exhibited significantly smaller temporal lobe and hippocampal volumes, with a trend for smaller amygdala volumes.
Introduction
Catechol-O-methyl transferase (COMT) is a methylation enzyme engaged in the degradation of norepinephrine and dopamine. Of particular interest is a functional single nucleotide polymorphism resulting in the substitution of methionine (Met) for valine (Val) at codon 158 (Val158Met) (Lachman et al., 1996) . The Met158 enzyme exhibits approximately one-fourth the activity of the Val158 enzyme, presumably resulting in greater synaptic levels of dopamine.
Structural neuroimaging studies examining this polymorphism are limited. Studies in healthy individuals show no effect of this polymorphism on total gray or white matter volumes (Zinkstok et al., 2006) or frontal lobe volume (Ho et al., 2005) . However, individuals with schizophrenia but not healthy controls who were COMT Val homozygotes exhibited reduced volumes of the left amygdala and right temporal lobe (Ohnishi et al., 2006) .
We tested for an association between COMT Val158-Met genotype and hippocampus, amygdala, and temporal lobe volumes in healthy adults. Although others found such a relationship only in individuals with schizophrenia (Ohnishi et al., 2006) , their findings guided our hypothesis that Val homozygotes would exhibit smaller temporal volumes than Met allele carriers. We also measured the caudate as a control region that we hypothesized would not be related to genotype. 
